ARCHIVES

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

This article is from The Cancer Letter archive.

Vol. 16 No. 43 | November 9, 1990

Download PDF Visit The Full Archive

Related Articles

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983